Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan · Delayed Price · Currency is TWD 32.20
+0.05 (0.16%)
Aug 29, 2025, 2:36 PM CST
Taiyen Biotech Revenue
Taiyen Biotech had revenue of 857.20M TWD in the quarter ending June 30, 2025, with 6.65% growth. This brings the company's revenue in the last twelve months to 3.30B, down -0.14% year-over-year. In the year 2024, Taiyen Biotech had annual revenue of 3.24B, down -5.01%.
Revenue (ttm)
3.30B
Revenue Growth
-0.14%
P/S Ratio
1.95
Revenue / Employee
7.33M
Employees
450
Market Cap
6.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.24B | -170.66M | -5.01% |
| Dec 31, 2023 | 3.41B | -204.80M | -5.67% |
| Dec 31, 2022 | 3.61B | -482.04M | -11.77% |
| Dec 31, 2021 | 4.10B | 965.30M | 30.84% |
| Dec 31, 2020 | 3.13B | 223.73M | 7.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Uni-President Enterprises | 675.60B |
| President Chain Store | 346.04B |
| Great Wall Enterprise | 102.84B |
| Lian Hwa Foods | 12.75B |
| Charoen Pokphand Enterprise (Taiwan) | 28.10B |
| Standard Foods | 28.88B |
| TTET Union | 21.60B |
| TCI Co., Ltd. | 7.13B |